TYRA BIOSCIENCES INC (TYRA) Stock Analyst Earnings Estimates
NASDAQ:TYRA - Nasdaq - US90240B1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 772.51% | N/A 173.81% | N/A 97.39% | N/A 95.94% | N/A 66.65% | |||||||
| EBITDA YoY % growth | -3.11M | -9.25M -197.43% | -26.15M -182.70% | -58.63M -124.21% | -79.592M -35.75% | -103.658M -30.24% | N/A -30.24% | N/A -12.20% | N/A -20.87% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.12M | -9.3M -198.08% | -26.29M -182.69% | -58.93M -124.15% | -79.945M -35.66% | -104.177M -30.31% | N/A -36.65% | N/A -18.64% | N/A -11.28% | N/A 15.49% | N/A 65.56% | N/A 315.90% | N/A 356.19% | N/A 93.20% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.33 4.36% | -1.61 -21.05% | -1.51 6.21% | N/A -43.04% | N/A -12.28% | N/A -8.43% | N/A 83.71% | N/A 1,157.14% | N/A 179.73% | N/A 82.13% | N/A 54.64% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 -68.54% | -0.55 -35.27% | -0.58 -35.21% | -0.59 -25.33% | -0.49 9.60% | -0.51 8.23% | -0.55 4.74% |
| Revenue Q2Q % growth | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | -32.12M -37.95% | -32.997M -16.89% | -34.486M -18.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.211M -45.38% | -36.41M -27.29% | -38.733M -30.22% | -37.414M -17.47% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.47 -34.29% | -0.50 | 0.03 | 5.89% |
| Q4 2024 Q2Q % growth | -0.43 18.87% | -0.49 | 0.06 | 12.26% |
| Q3 2024 Q2Q % growth | -0.41 16.33% | -0.41 | 0.00 | -0.82% |
| Q2 2024 Q2Q % growth | -0.32 -3.23% | -0.42 | 0.10 | 23.17% |
| Q1 2024 Q2Q % growth | -0.35 -25.00% | -0.46 | 0.11 | 24.61% |
| Q4 2023 Q2Q % growth | -0.53 -70.97% | -0.49 | -0.04 | -8.10% |
| Q3 2023 Q2Q % growth | -0.49 -63.33% | -0.36 | -0.13 | -36.22% |
| Q2 2023 Q2Q % growth | -0.31 13.89% | -0.35 | 0.04 | 11.57% |
| Q1 2023 Q2Q % growth | -0.28 22.22% | -0.37 | 0.09 | 25.00% |
| Q4 2022 Q2Q % growth | -0.31 -29.17% | -0.37 | 0.06 | 15.58% |
| Q3 2022 Q2Q % growth | -0.30 58.33% | -0.42 | 0.12 | 27.82% |
| Q2 2022 Q2Q % growth | -0.36 | -0.32 | -0.04 | -11.45% |
| Q1 2022 Q2Q % growth | -0.36 | -0.20 | -0.16 | -76.47% |
| Q4 2021 Q2Q % growth | -0.24 | -0.21 | -0.03 | -12.04% |
| Q3 2021 Q2Q % growth | -0.72 | -0.30 | -0.42 | -143.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.4% | -0.41% | -1.04% | 2.39% |
| Revenue | N/A | N/A | N/A | N/A |